DrugPatentWatch Database Preview
Olaratumab - Biologic Drug Details
» See Plans and Pricing
Summary for olaratumab
| Tradenames: | 1 |
| Patents: | 11 |
| Applicants: | 1 |
| BLAs: | 1 |
| Recent Clinical Trials: | See clinical trials for olaratumab |
Recent Clinical Trials for olaratumab
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Yonsei University | Phase 1/Phase 2 |
| Apexigen, Inc. | Phase 2 |
| Columbia University | Phase 2 |
Patent Text Search: US Patents for olaratumab
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eli Lilly And Co | LARTRUVO | olaratumab | INJECTABLE; INJECTION | 761038 | 001 | 2019-07-10 | Start Trial | biOasis Technologies, Inc. (Vancouver, British Columbia, unknown) | 2031-08-05 | RX | Orphan | search |
| Eli Lilly And Co | LARTRUVO | olaratumab | INJECTABLE; INJECTION | 761038 | 001 | 2019-07-10 | Start Trial | biOasis Technologies, Inc. (Richmond, CA) | 2033-03-13 | RX | Orphan | search |
| Eli Lilly And Co | LARTRUVO | olaratumab | INJECTABLE; INJECTION | 761038 | 001 | 2019-07-10 | Start Trial | SAMSUNG ELECTRONICS CO., LTD. (Suwon-Si, KR) | 2033-05-29 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for olaratumab
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 6502619 | Start Trial |
| Australia | 2019202704 | Start Trial |
| Russian Federation | 2014137109 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
